Your browser doesn't support javascript.
loading
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
Aljurf, Mahmoud; Weisdorf, Daniel; Hashmi, Shahrukh; Nassar, Amr; Gluckman, Eliane; Mohty, Mohamad; Rizzo, Doug; Pasquini, Marcelo; Hamadani, Mehdi; Saber, Wael; Hari, Parameswaran; Kharfan-Dabaja, Mohamed; Majhail, Navneet; Gerges, Usama; Hamidieh, Amir Ali; Hussain, Fazal; Elhaddad, Alaa; Mahmoud, Hossam K; Tbakhi, Abdelghani; Othman, Tarek Ben; Hamladji, Rose-Marie; Bekadja, Mohamed Amine; Ahmed, Parvez; Bazarbachi, Ali; Adil, Salman; Alkindi, Salman; Ladeb, Saleh; Dennison, David; Patel, Moosa; Lu, Peihua; Quessar, Asma El; Okamoto, Shinichiro; Atsuta, Yoshiko; Alhejazi, Ayman; Ayas, Mouhab F; Ahmed, Syed O; Novitzky, Nickolas; Srivastava, Alok; Seber, Adriana; Solh, Hassan El; Ghavamzadeh, Ardeshir; Confer, Dennis; Kodera, Yoshihisa; Hildegard, Greinix; Szer, Jeff; Horowitz, Mary M; Niederwieser, Dietger.
Afiliação
  • Aljurf M; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Electronic address: maljurf@kfshrc.edu.sa.
  • Weisdorf D; University of Minnesota, Minneapolis, Minnesota.
  • Hashmi S; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Nassar A; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Gluckman E; Eurocord Hôpital Saint-Louis and University Paris Diderot, Paris, France.
  • Mohty M; Hopital Saint-Antoine, Sorbonne University, Paris, France.
  • Rizzo D; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Pasquini M; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Hamadani M; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Saber W; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Hari P; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Kharfan-Dabaja M; Department of Medicine, Division of Hematology-Oncology and Blood and Marrow Transplantation program, Mayo Clinic, Jacksonville, Florida.
  • Majhail N; Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.
  • Gerges U; Hematologic Malignancies & Bone Marrow Transplant, Department of Medicial Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York.
  • Hamidieh AA; Hematology, Oncology and SCT Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Hussain F; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Elhaddad A; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Mahmoud HK; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Tbakhi A; King Hussein Cancer Center, Amman, Jordan.
  • Othman TB; Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
  • Hamladji RM; Pierre and Marie Curie Center, Algiers, Algeria.
  • Bekadja MA; University Hospital Establishment 1st Nov, Oran, Algeria.
  • Ahmed P; Armed Forces Institute of Transplantation, Rawalpindi, Pakistan.
  • Bazarbachi A; Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Adil S; Aga Khan University Hospital, Karachi, Pakistan.
  • Alkindi S; Sultan Qaboos University Hospital, Muscat, Oman.
  • Ladeb S; Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
  • Dennison D; Sultan Qaboos University Hospital, Muscat, Oman.
  • Patel M; University of the Witwatersrand, Johannesburg, South Africa.
  • Lu P; Hebei Yanda Ludaopei Hospital, Langfang, China.
  • Quessar AE; Hôpital 20 Août, Casablanca, Morocco.
  • Okamoto S; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Atsuta Y; Keio University School of Medicine, Tokyo, Japan.
  • Alhejazi A; King Abdulaziz Medical City, NGHA, Riyadh, Saudi Arabia.
  • Ayas MF; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Ahmed SO; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Novitzky N; African Blood & Marrow Transplantation Society, South Africa.
  • Srivastava A; Christian Medical College and Hospital, Bagayam, Vellore, India.
  • Seber A; Instituto de Oncologia Pediatrica, Sao Paulo, Brazil.
  • Solh HE; Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Ghavamzadeh A; Hematology, Oncology and SCT Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Confer D; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Kodera Y; Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.
  • Hildegard G; Medical University of Graz, Graz, Austria.
  • Szer J; Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia.
  • Horowitz MM; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
  • Niederwieser D; Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan; Department of Hematology and Medical Oncology, University Hospital, Leipzig, Germany.
Biol Blood Marrow Transplant ; 25(12): 2330-2337, 2019 12.
Article em En | MEDLINE | ID: mdl-31002990
ABSTRACT
The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Países em Desenvolvimento Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Países em Desenvolvimento Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article